Tenet Healthcare (THC) Stock Chart - Revenue & Earnings | Quarter Chart
Revenue by Product
Revenue by Geography
Revenue, Gross Profit, Operating and Net Income
Margin (%)
Operating Expenses
EBITDA
EPS
Revenue Variation (%)
Income Variation (%)
Revenue YoY Variation (%)
Income YoY Variation (%)
Price-to-Earning Ratio
Income Breakdown
Per Share Metrics
Expense Ratios
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt Ratio
Current Ratio
Quick Ratio
Cash & Equivalents
Total Assets
Total Liabilities
Shareholders Equity
Asset Composition
Debt Structure
Tenet Healthcare (THC) quarterly earnings & revenue
Tenet Healthcare (THC) reported revenue of $5.37B for Q1 2026, up 2.8% year-over-year, with net income of $702.00M and diluted EPS of $8.01.
Over the last four reported quarters, Tenet Healthcare generated $21.45B in revenue and $1.70B in net income.
Tenet Healthcare's next earnings report is scheduled for July 24, 2026 before market open; analysts estimate EPS of $4.23.
Tenet Healthcare quarterly results
| Fiscal quarter | Revenue | Revenue YoY | Net income | EPS (diluted) |
|---|---|---|---|---|
| Q1 2026 | $5.37B | +2.8% | $702.00M | $8.01 |
| Q4 2025 | $5.53B | +9.0% | $371.00M | $4.22 |
| Q3 2025 | $5.29B | +3.3% | $342.00M | $3.86 |
| Q2 2025 | $5.27B | +3.3% | $288.00M | $3.14 |
| Q1 2025 | $5.22B | -2.7% | $406.00M | $4.27 |
| Q4 2024 | $5.07B | -5.7% | $318.00M | $3.32 |
| Q3 2024 | $5.12B | +1.1% | $472.00M | $4.89 |
| Q2 2024 | $5.10B | +0.4% | $259.00M | $2.64 |
Tenet Healthcare (THC) — frequently asked questions
When does Tenet Healthcare (THC) report earnings next?
Tenet Healthcare is expected to report earnings on July 24, 2026 before market open. Analysts estimate EPS of $4.23.
What was THC's revenue last quarter?
Tenet Healthcare reported revenue of $5.37B in Q1 2026, up 2.8% from the same quarter a year earlier.
What was THC's EPS last quarter?
Tenet Healthcare reported diluted EPS of $8.01 in Q1 2026.
Is Tenet Healthcare profitable?
Tenet Healthcare is currently profitable, with $1.70B in net income over the last four reported quarters.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Roche (ROG.SW) · Merck (MRK)